Valneva SE has appointed Vincent Dequenne as Senior Vice President Operations and Joshua Drumm as Vice President Investor Relations.
 
Vincent Dequenne has an extensive track record in the pharmaceutical industry with more than 20 years of manufacturing and production experience including leadership roles at Eli Lilly, GSK vaccines, Pierre Fabre and most recently Eurogentec. Vincent will take responsibility for Valneva’s industrial operations and work closely with Valneva’s Chief Operating Officer Perry Celentano.
 
Joshua Drumm brings more than 12 years of experience in Investor Relations for both public and privately held life sciences companies. He holds a Ph.D. in Microbiology and Immunology and certificates in Financial Accounting and Financial Modeling from New York University.
 
Joshua will focus on developing the company’s Investor Relations in the U.S. following its recent Initial Public Offering. He will work closely with Laetitia Bachelot-Fontaine who will continue to lead European Investor Relations and Global Communications. Josh will be based in Boston.
 
Thomas Lingelbach, Chief Executive Officer of Valneva, said, “I’m delighted to welcome Vincent and Joshua on board along with their extensive experience. Valneva is going from strength to strength and it’s important that we continue to build our senior management team to accompany this growth.”